TELEFLEX INC
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
TFX$155.30+0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Nine Months Ended | ||
|---|---|---|
| September 30, 2026 | September 28, 2025 | |
| (Dollars in thousands) | ||
| Cash flows from operating activities of continuing operations: | ||
| Net income | $1,018,966 | $(191,310) |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| (Income) loss from discontinued operations | (927,755) | 253,393 |
| Depreciation expense | 53,330 | 39,177 |
| Intangible asset amortization expense | 101,815 | 84,986 |
| Deferred financing costs and debt discount amortization expense | 4,224 | 3,181 |
| Loss on extinguishment of debt | 4,531 | — |
| Changes in contingent consideration | (2,731) | 16,075 |
| Stock-based compensation | 18,448 | 19,002 |
| Asset impairment charge | — | 108,117 |
| Gain on non-designated foreign currency forward contracts | — | (82,636) |
| Deferred income taxes, net | 1,163 | (37,536) |
| Interest benefit on swaps designated as net investment hedges | (23,159) | (13,254) |
| Other | (425) | (4,961) |
| Changes in assets and liabilities, net of effects of acquisitions and disposals: | ||
| Accounts receivable | (40,717) | (94,934) |
| Inventories | 10,158 | 52,831 |
| Prepaid expenses and other assets | (4,178) | (24,245) |
| Accounts payable, accrued expenses and other liabilities | 35,422 | (24,329) |
| Income taxes receivable and payable, net | (14,258) | (93,287) |
| Net cash provided by operating activities from continuing operations | 234,834 | 10,270 |
| Cash flows from investing activities of continuing operations: | ||
| Expenditures for property, plant and equipment | (54,438) | (71,418) |
| Proceeds from sale of business and assets | — | 6,712 |
| Payments for businesses and intangibles acquired, net of cash acquired | — | (831,857) |
| Proceeds from non-designated balance sheet hedges | — | 82,203 |
| Insurance settlement proceeds | — | 9,447 |
| Net payments on swaps designated as net investment hedges | (38,308) | 7,612 |
| Proceeds from sales of investments | 17 | — |
| Purchase of investments | (9,000) | (5,000) |
| Net cash used in investing activities from continuing operations | (101,729) | (802,301) |
| Cash flows from financing activities of continuing operations: | ||
| Proceeds from new borrowings | 2,350,000 | 1,140,000 |
| Reduction in borrowings | (3,368,125) | (121,750) |
| Repurchase of common stock | (554,951) | (300,000) |
| Net (payments) proceeds from share based compensation plans and related tax impacts | (5,383) | 7,161 |
| Share repurchase excise tax | (2,802) | (1,894) |
| Payments for contingent consideration | (156) | (166) |
| Dividends paid | (43,748) | (45,242) |
| Debt extinguishment, issuance and amendment fees | (16,098) | (4,961) |
| Net cash (used in) provided by financing activities from continuing operations | (1,641,263) | 673,148 |
| Cash flows from discontinued operations: | ||
| Net cash provided by operating activities | 56,279 | 178,200 |
| Net cash provided by (used in) investing activities | 1,482,576 | (24,481) |
| Net cash provided by discontinued operations | 1,538,855 | 153,719 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents | (7,036) | 18,824 |
| Net increase in cash, cash equivalents and restricted cash equivalents | 23,661 | 53,660 |
| Cash, cash equivalents and restricted cash equivalents at the beginning of the period | 453,848 | 327,650 |
| Less: Cash, cash equivalents and restricted cash of discontinued operations | (33,181) | (44,801) |
| Cash, cash equivalents and restricted cash equivalents at the end of the period | $444,328 | $336,509 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.